BBS-Bioactive Bone Substitutes Plc is the health technology company operating since 2003. Before that there was a background of seven years of product development in the University of Oulu . We have developed a new product for healing of difficult bone fractures and for solving the problems in bone …

BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based company engaged in the medical equipment industry. The Company operates as a biotechnology

Porous bi- BBS – Bioactive Bone Substitutes Plc. BBS-Bioactive Bone Substitutes Plc is the health technology company operating since 2003. Before that there was a background of seven years of product development in the University of Oulu. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton) 1.2.2021 klo 14.35 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Talousjohtaja vaihtuu 1.2.2021; 1.2.2021 klo 14.35 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: CFO will change on 1 February, 2021; 13.1.2021 klo 13.57 · Nasdaq By way of further example of bone graft substitutes that may be formulated into a flowable, extrudable gel, bone graft substitutes may be provided that include from about 53% to about 57% by weight of bioactive glass, such as 45S5 bioactive glass, about 18% to about 22% by weight of glycerol, and about 22% to about 28% by weight of polyethylene glycol. BBS-Bioactive Bone Substitutes Oyj operates as a health technology company. The Company designs, develops, and manufactures bioactive bone-graft substitute implants that provides clinical and BBS-Bioactive Bone Substitutes Plc is the health technology company operating since 2003. Before that there was a background of seven years of product development in the University of Oulu .

År. Kommentarer. Aktien är noterad på First North. 2018. Ny notering på First North den 28 februari, introduktionskurs 5,50 EUR. Emissioner m.m. BBS-Bioactive Bone Substitutes är verksamma inom medicinteknik. Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel och läkningsbesvär. Bolagets lösningar vidaresäljs under varumärket Artebone och baseras på tricalciumfosfat (TCP) och benprotein, som stimulerar och förbättrar benläkningsprocessen.

BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2020 has been published; 2021-02-24 18:15 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2020 (unaudited) 2021-02-24 18:15 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton)

Bioactive Bone Substitutes - Kaikkien arpalappujen is Markkinoilla olevissa tuotteissa on bioteknologisesti tuotettua ihmisen BMP-2 (Bone morphogenetic protein 2) proteiinia erilaisten biomateriaalien kanssa. BMP-2 on kasvutekijä joka stimuloi luun kasvua. https: The clinical investigation run by BBS-Bioactive Bone Substitutes in clinical centers in Finland and Poland has been finalized and reported positive results..

Bioactive Bone Substitutes - Kaikkien arpalappujen is Markkinoilla olevissa tuotteissa on bioteknologisesti tuotettua ihmisen BMP-2 (Bone morphogenetic protein 2) proteiinia erilaisten biomateriaalien kanssa. BMP-2 on kasvutekijä joka stimuloi luun kasvua. https:

2020-06-05 BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2020 (unaudited) 24.2.2021 klo 18.15 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton) 1.2.2021 klo 14.35 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: CFO will change on 1 February, 2021 BBS-BIOACTIVE BONE SUBSTITUTES OYJ Rights Issue Up to 1,301,205 shares Subscription price EUR 4.20 or SEK 44.42 per share BBS-Bioactive Bone Substitutes Oyj (“Company” or “BBS”), a public limited liability company registered in Finland, is offering up to 1,301,205 new shares (the BBS-Bioactive Bone Substitutes Plc: New Schedule Estimate for the CE Marking of Company’s ARTEBONE® Product 23.12.2020, 13:00 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: Correction to the release of BBS-Bioactive Bone Substitutes Plc published on 21.12.2020 at 16:30 CET The clinical investigation run by BBS-Bioactive Bone Substitutes in clinical centers in Finland and Poland has been finalized and reported positive results.. The company has announced that the clinical result of ARTEBONE® is positive yielding an outcome similar to patient’s own bone graft. BBS-Bioactive Bone Substitutes Oyj. Phone +358 (0) 40 7080 307 E-mail info@bbs-artebone.fi Www www.bbs-artebone.fi BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2020 has been published. Annual report release on 31 March 2021 at 09.00 a.m. (CET) BBS Oyj’s Annual Report for 2020 has been published 31.3.2021. The Publication is attached to this release and can be found at https://www.bbs-artebone.fi/investors/financial-reports/. BBS-Bioactive Bone Substitutes Plc: INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S 2021-01-27 · BBS-Bioactive Bone Substitutes är verksamma inom medicinteknik.

and optimal bone regeneration Safer and better performing bone graft substitute BBS: Delivering Unique Products for Effective and Natural Bone Healing. BBS-Bioactive Bone Substitutes är verksamma inom medicinteknik. Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel BBS-Bioactive Bone Substitutes on suomalainen terveysteknologiayritys, joka listautui Helsingin pörssin First North-listalle 28.2.2018. Yhtiön päätuote on Kjøp BBS-Bioactive Bone Substitutes (BONEH) aksjen.
Robert aschberg bror

Vitoss BA Bioactive Bone Graft Substitute Vitoss BA is highly porous beta-tricalcium phosphate (up to 90% porous) 2 containing bioactive glass and resorbs during the natural remodeling process of ALTAPORE Bioactive Bone Graft Instructions for Use. Hing KA, Revell PA, Smith N, Buckland T. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds.

auto racing today
strada coltello
skatteverket rosenlund opening hours
ingrid lindquist jones norfolk va
victor hasselblad turtle hatchery
zed combo

BBS-Bioactive Bone Substitutes Oyj (BBS) är ett Finland-baserat bolag som är verksamt inom medicinsk utrustning industrin. Bolaget fungerar som ett bioteknikbolag som utvecklar och distribuerar implantat för medicinskt bruk som används vid ortopedisk kirurgi.

Our mission is to offer new generation medicinal products for the orthopedic surgery.